TITLE

DID YOU KNOW?

PUB. DATE
March 2009
SOURCE
HealthLeaders Magazine;Mar2009, Vol. 12 Issue 3, p14
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article looks at the higher spending of Americans on prescription drugs compared to other industrialized countries in Europe. According to a report, patients in the U.S. spend each year $98 billion on medications which are more than those of other countries. Also included is an overview of comparative costs of medication and new drugs between the U.S. and in Europe.
ACCESSION #
36829015

 

Related Articles

  • Understanding the effects of pharmaceutical promotion: a neural network approach guided by genetic algorithm-partial least squares. Chee Wooi Lim; Kirikoshi, Toru // Health Care Management Science;Dec2008, Vol. 11 Issue 4, p359 

    With escalating healthcare costs and increasing concerns about optimizing use of medicine, there is an unresolved debate over years around the potential impact of pharmaceutical promotion on physicians’ prescribing behaviors. What should be the appropriate balance of promotion dollars to...

  • Pricing dynamics and product quality: the case of antidepressant drugs. Chen, Jie; Rizzo, John // Empirical Economics;Feb2012, Vol. 42 Issue 1, p279 

    The rising prices of pharmaceuticals have generated considerable, and often acrimonious, debate. Yet, there is little conceptual work or empirical evidence on pharmaceutical pricing strategies or on the time paths of these prices. This study provides a conceptual framework describing the...

  • Rx carve-outs escalate as cost control. Lee, Karen // Employee Benefit News;6/15/2002, Vol. 16 Issue 8, p17 

    Deals with the demand for prescription drug benefit cutbacks to control health care costs in the U.S. as of June 2002. Plan of the Manhattan Insurance Group to roll out a prescription drug plan that can be attached as a rider to other voluntary benefits; Benefits from the utilization of drugs;...

  • Putting a lid on prescription drug use. Doyle, B.G. // Caribbean Business;6/17/1999, Vol. 27 Issue 23, pS11 

    Suggests measures to control Puerto Rico's growing healthcare costs due to increasing use of prescription drugs. Includes pharmacy and physician audits; Factors responsible for the pharmacy cost trend; Concerns of healthcare insurers expressed by Felipe Benedict, president of Medical Card...

  • The Controversy Of Increased Spending For Antidepressants. Croghan, Thomas W. // Health Affairs;Mar/Apr2001, Vol. 20 Issue 2, p129 

    Comments on the controversy surrounding increased spending for antidepressants in the United States. Increased prices due to increased utilization of antidepressants; Reasons why increased use of antidepressants may include considerable amounts of unnecessary use; Quality and value of...

  • Is the current evidence on Medicare part D sufficient?  // PharmacoEconomics & Outcomes News;12/11/2010, Issue 618, p3 

    The article discusses research study on the association of changes in drug use and out-of-pocket costs with medicare part dimplementation, referencing a study by J. M. Polinski and colleagues published in the September 2010 issue of the "Journal of the American Geriatrics Society.

  • Improve medication use and avoid costs.  // PharmacoEconomics & Outcomes News;6/29/2013, Issue 681, p3 

    The article discusses research being done on the annual savings opportunity provided by the responsible use of medicines, which references a study published online by IMS Health on June 19, 2013.

  • HMOs, doctors chafe at Consumer Drug ads. Baiocchi, Chris // Orange County Business Journal;02/22/99, Vol. 28 Issue 8, p28 

    Reports that direct consumer advertising by pharmaceutical companies are painting an incomplete picture of different drugs, and are causing patients to demand brand-name, big-ticket drugs according to critics. Need to educate consumers; US Food and Drug Administration regulation about drug...

  • Spending on speciality drugs set to rise.  // PharmacoEconomics & Outcomes News;5/25/2013, Issue 679, p11 

    The article reports on a study made public by Express Scripts which has projected a 67% increase in spending on specialty drugs in the U.S.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics